Palisade Bio (PALI) Total Liabilities (2010 - 2026)

Palisade Bio (PALI) has 17 years of Total Liabilities data on file, last reported at $6.0 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $6.0 million, up 108.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (up 108.22% YoY), and the FY2025 annual result was $5.0 million, up 46.52% from the prior year.
• Total Liabilities climbed to $6.0 million in Q1 2026 per PALI's latest filing, from $5.0 million in the prior quarter.
• Over five years, Total Liabilities peaked at $6.0 million in Q1 2026 and troughed at $1.5 million in Q1 2023.
• A 5-year average of $3.4 million and a median of $3.3 million in 2022 frame the typical range for Total Liabilities.
• On a YoY basis, Total Liabilities climbed as much as 199.97% in 2022 and fell as far as 85.26% in 2022.
• A 5-year view of Total Liabilities shows it stood at $3.3 million in 2022, then decreased by 16.6% to $2.7 million in 2023, then grew by 23.69% to $3.4 million in 2024, then jumped by 46.52% to $5.0 million in 2025, then grew by 19.92% to $6.0 million in 2026.
• Business Quant data shows PALI's Total Liabilities at $6.0 million in Q1 2026, $5.0 million in Q4 2025, and $3.8 million in Q3 2025.